BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1068348)

  • 1. Leukaemia of the myeloid series in patients with Hodgkin's disease.
    Stenfert Kroese WF; Sizoo W; Somers R
    Neth J Med; 1976; 19(4-5):234-8. PubMed ID: 1068348
    [No Abstract]   [Full Text] [Related]  

  • 2. Hodgkin's disease terminating in acute myeloid leukaemia.
    Mauri C; Quaglino D
    Haematologica; 1974 Mar; 59(1):86-90. PubMed ID: 4213144
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukaemia in Hodgkin's disease.
    Falkson HC; Portugal MA; Falkson G
    S Afr Med J; 1976 Aug; 50(3F):1429-31. PubMed ID: 1067672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hodgkin's disease evolving into acute leukemia. Report of 2 cases].
    Armenta D; Pretty HM; Long LA; Neemeh JA; Gosselin G
    Union Med Can; 1975 May; 104(5):744-8. PubMed ID: 1056113
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cyclic polychemotherapy of Hodgkin's disease].
    Berényi E; Szegedi G
    Orv Hetil; 1984 Oct; 125(41):2477-81. PubMed ID: 6493760
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of polychemotherapy and its complications in late stages of Hodgkin's disease].
    Anikin BS; Kaganov AL; Tarlova RM
    Ter Arkh; 1976; 48(8):73-9. PubMed ID: 1024302
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of betamethasone in polychemotherapy of lymphoproliferative diseases].
    Cellerino R; Ambrosetti A; Tummarello D; Perini A; Piga A; Celebrano M
    Minerva Med; 1980 Sep; 71(32):2293-7. PubMed ID: 6933321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trial treatment of acute leukemia and Hodgkin's disease with rubidomycin (or daunomycin) alone or in combination].
    Mathé G; Amiel JL; Hayat M; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Ceoara B
    Sem Hop; 1967 Jul; 43(32):2108-14. PubMed ID: 4292321
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gonadal hypotrophy and acute leukemia after chemotherapy for Hodgkin's disease. Report of a case (author's transl)].
    Lebreton C; Grange MJ; Tchernia G; Schweisguth O
    Arch Fr Pediatr; 1981 Nov; 38(9):697-9. PubMed ID: 6949500
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polychemotherapy of generalized forms of Hodgkin's disease].
    Koverzneva MM; Kondrat'eva AP; Lorie IuI
    Ter Arkh; 1976; 48(8):84-8. PubMed ID: 1024303
    [No Abstract]   [Full Text] [Related]  

  • 13. [A reserve chemotherapy for Hodgkin's disease (author's transl)].
    Amiel JL; Ayed FB; Droz JP; Tursz T; Brule CH
    Nouv Presse Med; 1980 Oct; 9(37):2705-6. PubMed ID: 6159573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease.
    De Lena M; Monfardini S; Beretta G; Fossati-Bellani F; Bonadonna G
    Natl Cancer Inst Monogr; 1973 May; 36():403-20. PubMed ID: 4126720
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
    Sutcliffe SB; Economopoulos T; Wrigley PF; Stansfeld AG; Malpas JS
    Clin Oncol; 1980 Dec; 6(4):329-36. PubMed ID: 6161731
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensive chemotherapy for Hodgkin's disease: long-term complications.
    DeVita VT; Arseneau JC; Sherins RJ; Canellos GP; Young RC
    Natl Cancer Inst Monogr; 1973 May; 36():447-54. PubMed ID: 4744600
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nephrotic syndrome in Hodgkin's disease].
    Capra Marzani M
    Arch Sci Med (Torino); 1981; 138(4):543-56. PubMed ID: 7041852
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute leukaemia in the course of Hodgkin's disease: report of two cases (author's transl)].
    Mitrou PS; Fischer M; Martin H
    Dtsch Med Wochenschr; 1974 Aug; 99(31):1596-7. PubMed ID: 4526423
    [No Abstract]   [Full Text] [Related]  

  • 19. [Leurosine, the 3d alkaloid from Vinca rosea, in the treatmen t of Hodgkin's disease, acute lymphoblastic leukemia and lymphoblastosarcoma].
    Schneider M; Band P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR; Mathé G
    Sem Hop; 1966 Nov; 42(49):2952-4. PubMed ID: 4292621
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum copper assay as a biochemical marker to assess the response to therapy in Hodgkin's disease.
    Kesava Rao KV; Shetty PA; Bapat CV; Jussawalla DJ
    Indian J Cancer; 1977 Dec; 14(4):320-4. PubMed ID: 612553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.